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Abstract Hemocytes from the invertebrate Styela clava, a 
solitary tunicate, contained a family of four α-helical anti-
microbial peptides that were purified, sequenced and named 
clavanins A, B, C and D. Each clavanin contained 23 amino acid 
residues and was C-terminally amidated. The tunicate peptides 
resembled magainins in size, primary sequence and antibacterial 
activity. Synthetic clavanin A was prepared and displayed 
comparable antimicrobial activity to magainins and cecropins. 
The presence of α-helical antimicrobial peptides in the hemocytes 
of a urochordate suggests that such peptides are primeval 
effectors of innate immunity in the vertebrate lineage. 
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1. Introduction 
Various antimicrobial peptides have been found in mamma-
lian [1-3] and avian [4] leukocytes, amphibian skin [5,6], bo-
vine lingual and respiratory tract epithelia [7,8] and the gas-
trointestinal and genitourinary cells of humans [9,10] and 
other mammals [11,12]. Given this widespread distribution, 
we sought homologues of these peptides in the hemocytes of 
tunicates, simple marine protochordates that are ancestral to 
early vertebrates [13]. Tunicate 'hemocytes' are phagocytic 
cells that correspond to the leukocytes of higher vertebrates 
[14]. This report describes four members of a 'new' family of 
antimicrobial peptides, clavanins. We derived the word clava-
nin from the Latin word clava (club), an ancient but still 
effective weapon of host defense. 
2. Materials and methods 
2.1. Tunicate hemocytes 
Freshly harvested, live Styela clava were obtained from a local 
supplier (Marinus Biologicals, Long Beach, CA). Their tunics were 
bathed briefly in absolute ethanol, blotted dry and transected peribas-
ally over a 50 ml test tube that contained 0.25 g of disodium EDTA. 
Hemolymph was collected dripwise through a Netwell polyester sieve 
with 74 μτη apertures (Corning Costar, Cambridge, MA) to remove 
cellular aggregates. Processing 50 tunicates in a batch yielded approxi-
mately 2X108 hemocytes. These cells were centrifuged at 260 Xg for 
5 min at 4°C, resuspended in 50 ml of 0.34 M sucrose and recentri-
fuged as above. The recovered hemocytes were placed into ice-cold 5% 
acetic acid, briefly sonicated, stirred overnight at 4°C and clarified by 
centrifugation at 27000Xg for 30 min. The supernatant, which con-
tained « 1 5 mg protein/2 X 108 hemocytes by BCA analysis, was re-
covered for further analysis. 
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2.2. Purification of antimicrobial peptides 
Clavanins were identified and purified from these supernatants by a 
3-stage procedure that began with ultrafiltration through a 10 kDa 
cutoff Amicon YM-10 membrane, followed by either gel permeation 
chromatography or preparative acid-urea polyacrylamide gel electro-
phoresis [15], followed by reverse-phase HPLC. The YM-10 filtrates 
contained =3.5 mg of protein/2 X108 hemocytes and were concen-
trated to 2 ml by vacuum centrifugation (Speed Vac, Savant Instru-
ments, Hicksville, NY) before chromatography on a 1.2 X 65 cm Bio-
Gel P-10 column that was eluted with 5% acetic acid. Because 
preparative acid-urea PAGE [15] was faster and afforded higher pur-
ity and recovery than gel chromatography, we used it increasingly as 
our studies progressed. Supernatants subjected to preparative PAGE 
were first lyophilized to dryness and resuspended in 2 ml of 5% acetic 
acid with 3 M urea and a trace of methyl green dye. Antimicrobial 
fractions were pooled as indicated, and purified by RP-HPLC a 
4.6X250 mm Vydac C18 column, using various linear gradients of 
acetonitrile in 0.1% trifluoroacetic acid (TFA) or 0.13% heptaflurobu-
tyric acid. 
Throughout the purifications, fractions were lyophilized, concen-
trated and tested for antimicrobial activity against Listeria monocyto-
genes strain EGD by a radial diffusion technique [16]. The underlay 
gels contained 9 mM sodium phosphate, 1 mM sodium citrate buffer, 
0.30 mg/ml of trypticase soy broth powder (BBL, Cockeysville, MD) 
and 1% agarose, and had a final pH of 6.5. The overlay gels (1% 
agarose and 60 mg/ml of trypticase soy broth powder, pH 7.3) were 
poured 3 h after adding the peptide samples to the underlay gel's 
sample wells. 
2.3. Peptide characterization 
Purified clavanins were hydrolysed in vacuo in 5.7 N HC1 for 20 h, 
derivatized with phenylisothiocyanate (PITC) and quantitated as 
phenylthiocarbamyl derivatives on a Picotag system (Waters Associ-
ates, Milford, MA). Amino acid sequences were determined by gas-
phase Edman degradation with a Porton Model 2090 instrument, 
using purified 300 pmol samples of clavanins. Mass spectrometric 
analyses of native clavanins were done at the UCLA Center for Mo-
lecular and Medical Mass Spectrometry, using a ZAB-SE Fast atom 
bombardment instrument (VG Instruments, Manchester, UK). 
Circular dichroism spectra were obtained on an AVIV model 62DS 
spectropolarimeter (AVIV Associates, Lakewood, NJ) at 23°C in a 
rectangular 0.5 mm path length cell that contained either 80% tri-
fluoroethylene (TFE) or unilamellar = 100 nm diameter liposomes 
in 10 mM phosphate buffer, pH 7.4. The liposomes, composed of a 
3:1 molar ratio of egg phosphatidylglycerol and cardiolipin, re-
sembled S. aureus membranes in composition [17] and were prepared 
by 'LiposoFast' extrusion (Avestin, Ottawa, Canada). 
2.4. cDNA cloning and sequencing 
Total RNA from tunicate pharyngeal tissues was isolated and pur-
ified using a total RNA Separator Kit (Clontech, Palo Alto, CA). 
First-strand cDNA synthesis and clavanin 3' side cDNA amplification 
were carried out with a 3' RACE Kit (Gibco BRL, Gaithersburg, 
MD). Total pharyngeal RNA (1 μg) and 10 μΜ adapter primer (1 
μΐ) were used to obtain the first cDNA strand. A degenerate 30-base 
primer (5'-GTCGACTAGTCAYCAYGTIGGIAAYTTYGT-3'), that 
corresponded to amino acids 11-17 of clavanms A, B, C, and D (His-
His-Val-Gly-Asn-Phe-Val) was synthesized. In the above notation, 
Y represents T or C and I represents inosine. The Spel restriction site 
is underlined. PCR was performed in a total volume of 50 μΐ that 
contained: 1/10 vol. of cDNA, 10 pmol degenerate primer, 10 pmol 
AUAP primer, and 5 U of pfu DNA polymerase. The reaction was 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
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Fig. 1. RP-HPLC purification of clavanins A-D. Main figure: Clavanin-enriched fractions after preparative acid-urea-PAGE were pooled and 
subjected to RP-HPLC. The acetonitrile gradient is shown by an interrupted lin. Peak 1 contained a mixture of clavanins A and B, while peak 
2 contained clavanins C and D. Inserts: The individual clavanins in peaks 1 and 2 were resolved by further RP-HPLC. 
run for 35 cycles, with 1 min denaturation (94°C), 1 min annealing 
(48°C), and 2.5 min extension (72°C) per cycle. PCR products about 
250 bp in size were cloned into pCRScript SK vector (Stratagene, La 
Jolla, CA). Sequencing was performed on the double-stranded plas-
mid by the fluorescein-labeled dideoxy nucleotide terminator method, 
and analyzed on an Applied Biosystems 373 DNA Sequencer (Perkin-
Elmer, Palo Alto, CA). 
2.5. Bacteriologic studies 
Peptides were mixed with mid-logarithmic phase E. coli or L. mono-
cytogenes in a sterile pH 6.5 solution that contained 10 mM sodium 
phosphate buffer and 0.3 mg/ml of trypticase soy broth powder. Such 
mixtures, typically in a final volume of 50-100 μΐ, were incubated in a 
37°C shaking water bath and 10 μΐ aliquots were removed at intervals 
and directly or after dilution were plated with a Spiral plater [18] 
(Spiral Systems Instruments, Bethesda, MD). The resulting colonies 
were counted after an overnight incubation. Magainin 1 and cecropin 
PI (both purchased from Bachem) were used as controls in these 
experiments. 
2.6. Synthetic clavanins 
Two forms of synthetic clavanin A, with a C-terminal carboxylic 
acid or amide, were synthesized by SynPep (Dublin, CA) using F-moc 
(9-fluoroenylmethyloxycarbonyl) chemistry. Their respective massav 
values were: acid, 2667.2 (expected 2667.1) and amide, 2664.6 (ex-
pected 2666.1). These peptides were purified to virtual homogeneity 
by RP-HPLC. 
3. Results 
Fig. 1 shows the last few stages in the purification of cla-
vanins A, B. C and D, accomplished by RP-HPLC. The pri-
mary sequences of these peptides are shown in Fig. 2. Each 
clavanin contained 23 residues, including an amidated C-ter-
minal phenylalanine. Eighteen of the 23 residues (78.3%) were 
identical in every clavanin and have been bolded. Fig. 2 also 
indicates the consensus clavanin primary structure. 
Clavanins A and B differed only by the conservative re-
placement of lys7 (in A) by arg7 in clavanin B. The measured 
mass of clavanin A, 2666.4, agreed with its calculated mass of 
2667.1. Because C-terminal amidation is common in antimi-
crobial peptides, we prepared synthetic clavanin A with and 
without an amidated C-terminal phenylalanine. Although the 
calculated and measured masses of clavanin B were almost 
identical (2695.0 and 2694.8, respectively), native clavanins 
A and B migrated identically on acid-urea P A G E gels signify-
ing that they had identical net charges (Fig. 3A). Native cla-
vanin A migrated identically to the amidated peptide by ac id-
urea P A G E , (Fig. 3B). Taken together, these results indicated 
that native clavanins A and B were both amidated. 
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Fig. 2. Primary sequences of clavanins A-D. The sequences are 
shown in standard single letter code. The following non-standard 
symbols have also been used: *, C-terminal amidation; Y, methyl-
tyrosine; D, a hydrophobic residue; Δ, a polar residue; A. a posi-
tively charged residue. In the consensus clavanin sequence, invariant 
residues have been bolded. Clavanin A is also aligned with magai-
nin 1, with the identical residues bolded and the highly conservative 
substitutions underlined. 
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Fig. 3. A: Acid-urea PAGE. Lane 1 contained 1 μg each of defensins HNP-1 (above) and NP-1 (below), used as standards. Lane 2: A mixture 
of clavanins A-D, 0.5 μg each. Lanes 3-6: 1 μg of clavanins A, B, C and D, respectively. The gel was stained with Coomassie Blue. B: Acid-
urea PAGE. Lane 1 contained 1 μg of human defensin HNP-1 as a standard. Lanes 2-A contained 1 μg each of native clavanin A, synthetic 
clavanin A amide and synthetic clavanin A acid, respectively. The native form migrated alongside the amidated synthetic clavanin (C). SDS-
PAGE. Both outside lanes (S) contained molecular weight standards. The remaining lanes contained 2 μg of a mixture of clavanins A-D (M), 
followed by 1 μg each of clavanins A,B,C and D (so labeled). The gel was silver-stained. 
We could identify 19 of the 23 residues of clavanins C and 
D by direct peptide sequencing and identified the remaining 
residues (tyri7, his2i, val22, phe23) by 3' RACE-PCR clon-
ing of a precursor whose (partial) sequence was HH-
VGNFVYGFSHVF(G). The full structures of the clavanin 
precursors will be described elsewhere (Zhao et al., unpub-
lished). By FAB-MS, the calculated masses of clavanins C 
and D (2682.1 and 2673.0, respectively) were 14 mass units 
less than their measured values, suggesting that one residue 
had been methylated. Because we found no unmodified tyro-
sine in the amino acid analyses (data not shown) of these 
clavanins, we concluded that the methylated residue was 
tyri7. The location of the tyrosine methyl group (a-, o- or 
N) in clavanins C and D remains to be determined. The pres-
ence and position of a glycine residue (G) in the clavanin C/D 
precursor [HHVGNFVYGFSHVF(G)] suggests that clavanins 
C and D are also amidated [19]. 
The presence of polar amino acids at relatively regular in-
tervals along the clavanin backbone suggested that the pep-
tides probably formed amphipathic helices. This conjecture 
CO 
X 
LU 
a? 
60 
0 
-20 
o 
E 
T3 
X 
CM 
E 
υ 
X 
ω 
D) 
ω "O 
40 -
20 -
'"'.' ■ 
,*■ \ 
1 
— ι « 1 ' 1 ' 1 ■ 1 ' I n I 
190 200 210 220 230 240 250 
Wavelength (nm) 
Fig. 4. Circular dichroism spectrum of synthetic clavanin A. The spectrum drawn with a solid line was obtained by placing 30 μg ml-1 of pep-
tide in a 4:1 mixture of trifluoroethanol (TFE) and 10 mM phosphate buffer, pH 7.4. The spectrum drawn with a dotted line was obtained by 
adding the peptide to a liposomal dispersion prepared from a 3:1 mixture of egg phosphatidylglycerol and cardiolipin in 10 mM phosphate 
buffer. The lipid/peptide ratio was 25:1. The insert shows a helical wheel projection of clavanin A. The incremental angle is 100°, the average 
hydrophobicity is 0.46 and the hydrophobic moment (μΗ) is 0.53. · , Hydrophobic residues; o, hydrophilic residues. 
I.H. Lee et al.lFEBS Letters 400 (1997) 158-162 161 
5 10 15 
Incubation time (min) 
Fig. 5. Activity of α-helical peptides against E. coli and L. monocy-
togenes. Incubations were performed at 37°C with mid-logarithmic 
phase organisms. The medium contained 10 mM sodium phosphate 
buffer (pH 6.5) and 0.3 mg/ml trypticase soy broth. · .■ . ▲ : L. 
monocytogenes CFU/ml; Oft Δ : E. coli. CFU/ml. The controls (no 
added peptides) are represented by inverted triangles (v , τ ) . All of 
the peptides were synthetic. They were tested at 3.5 μg/ml against 
L. monocytogenes and at 1.6 μg/ml against E. coli. 
was supported by our measurements of circular dichroism 
(Fig. 4). In 80% trifluoroethanol, the CD spectrum of syn-
thetic clavanin A (solid lines) contained a well-defined double 
minimum at -208 and 222 nm, characteristic of an rx-helical 
conformation. In phosphate buffer containing a liposomal dis-
persion whose composition simulated S. aureus membranes 
(dotted lines), the minima at «210 and 224 nm also indicated 
substantial α-helical conformation. 
A helical wheel projection of clavanin A demonstrated spa-
tial segregation of its hydrophobic and charged residues (Fig. 
4, insert), indicating the amphipathic nature of the clavanin 
oc-helix. Magainins [20], cecropins [21] and many other anti-
microbial peptides [22,23] also form amphipathic a-helices 
under conditions similar to those used in our experiments. 
We compared the abilities of clavanin A, magainin 1 and 
cecropin PI to kill mid-logarithmic phase Listeria monocyto-
genes and E. coli at pH 6.5 at 37°C (Fig. 5). Note that very 
low concentrations of clavanin A (and the other peptides) 
were rapidly bactericidal. After 5 min of incubation, 1.6 μ^ 
ml of clavanin A reduced the number of viable E. coli ML-35p 
by more than 2 logio and 3.5 μg/ml of clavanin A reduced the 
number of L. monocytogenes by more than 3 logio. 
Fig. 6 shows radial diifusion assays which compared the 
potency of native clavanins against L. monocytogenes, E. 
coli and C. albicans. In such assays, the X-intercepts of the 
plots indicate the minimal bactericidal concentrations. Note 
that clavanins C and D were approximately 3-5-fold more 
potent than clavanins A and B. 
4. Discussion 
We have shown that hemocytes of Styela clava, a solitary 
ascidian urochordate, contain clavanins, a family of broad-
spectrum rx-helical antimicrobial peptides. Figs. 2-5 indicate 
that clavanins show considerable structural [5] and functional 
[24] homology to magainin 1, a well-characterized antimicro-
bial peptide from the skin of Xenopus laevis. 
Magainin 2 is identical in sequence to magainin 1 except for 
its lysio and arg2i residues. Like clavanins, mature magainins 
contain 23 amino acids and are α-helical. Unlike clavainins, 
the magainins are not amidated. Although the 15 residues of 
clavanin A between Leu5 and Phe19 show 12 similarities (6 
identical residues and 6 conservative substitutions) to the res-
idues between He2 and Phe16 of magainin 1, magainins are 
lysine-rich peptides, whereas most of the positively charged 
residues of clavanins are histidines. Magainins are synthesized 
on a 303 residue prepropeptide that contains a single copy of 
magainin 1 and five copies of magainin 2 [25]. We will de-
scribe the structure of preproclavanins in a future communi-
cation. 
Several other examples of convergent or conserved structur-
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Fig. 6. Comparative activity of clavanins A, B, C and D. Serial 2-fold dilutions of native clavanins A-D were tested against E. coli ML-35p, 
L. monocytogenes EGD and C. albicans in radial diffusion assays. Zone diameters are expressed in units (10 U=l mm). Note that clavanins C 
and D were about 3-fold more active than clavanins A and B. 
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al motifs in the antimicrobial polypeptides of 'higher' and 
'lower' animals were recently reported. Amoebapore, a 77 
residue cytotoxic and antimicrobial pore-forming peptide 
from Entamoeba histolytica, a parasitic protozoan, shows con-
siderable homology to NK-lysin, a 78 residue antimicrobial 
peptide from porcine cytotoxic lymphocytes [26-28]. Simi-
larly, potently antimicrobial protegrin peptides found in por-
cine neutrophils [29] show considerable resemblance to tachy-
plesin peptides found in horseshoe crab hemocytes [30]. Since 
endogenous antimicrobial peptides occur in insects [31] and 
plants [32], antimicrobial peptides may have assumed their 
position in the immune arsenal of living organisms even be-
fore multicellular organisms existed and before animals and 
plants diverged. 
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